RxDoctor Payments Data

Robert White, MD

Neurology · Richmond, VANPI 1396718938

Payments from drug & device makers

$7,629in general payments, 2019–2025

Across 379 payments — averaging $20.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceuticals, Inc.$968
  • Novartis$658
  • EMD Serono, Inc.$615
  • AbbVie$382
  • UCB, Inc.$373
  • Biogen$335
  • plus $4K from 54 others

What the payments were for

  • Speaking & faculty fees$280%
  • Food & beverage$7,49998%
  • Education$1021%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biohaven Pharmaceuticals, Inc.13$968
Novartis48$658
EMD Serono, Inc.24$615
AbbVie(2 entities)21$382
UCB, Inc.23$373
Biogen20$335
Sanofi16$332
Teva Pharmaceuticals USA, Inc.11$267
Genentech USA, Inc.18$251
Grifols USA, LLC10$209
SK Life Science, Inc.7$191
Sunovion Pharmaceuticals Inc.11$186
AstraZeneca(2 entities)9$183
CSL Behring9$178
Amgen(2 entities)9$154
Amneal Pharmaceuticals LLC10$154
Lilly USA, LLC9$138
Lundbeck LLC8$127
Kyowa Kirin, Inc.5$112
ANI Pharmaceuticals, Inc.5$110
Neurelis, Inc.5$94
Banner Life Sciences, LLC4$94
Alnylam Pharmaceuticals Inc.5$81
Livanova USA, Inc.5$80
Promius Pharma LLC5$79
Eisai Inc.4$77
Catalyst Pharmaceuticals, Inc.3$71
Siemens Medical Solutions USA, Inc.4$71
Axsome Therapeutics, Inc.4$67
Supernus Pharmaceuticals, Inc.4$67
Acadia Pharmaceuticals Inc3$60
Greenwich Biosciences, Inc.4$60
Mallinckrodt Hospital Products Inc.2$52
Pfizer3$52
Neurocrine Biosciences, Inc.3$51
Adamas Pharmaceuticals, Inc.3$46
Bausch Health US, LLC2$42
Corium, LLC2$40
Mallinckrodt Enterprises LLC3$40
Abbott2$37
Tanabe Pharma America, Inc.1$35
Vertical Pharmaceuticals, LLC2$33
Bristol Myers Squibb2$31
Argenx US, Inc.1$31
Biohaven Pharmaceutical Holding Company Ltd.1$30
Acorda Therapeutics, Inc2$28
E.r. Squibb & Sons, L.L.C.1$27
Upsher-smith Laboratories LLC1$24
Akcea Therapeutics, Inc.1$22
TG Therapeutics, Inc.1$21
Cycle Pharmaceuticals Inc1$18
Johnson & Johnson1$18
Boston Scientific1$18
Ultragenyx Pharmaceutical Inc.1$17
Vanda Pharmaceuticals Inc.1$16
Scilex Pharmaceuticals Inc.1$15
GE HealthCare1$15
Harmony Biosciences LLC1$15
Avanir Pharmaceuticals, Inc.1$14
MDD US Operations, LLC1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,629 in reported general payments places this provider in the 65th percentile of 474 neurology providers in Virginia.

See all neurology providers in Virginia

Medicare billing

Part B allowed, 2024
$52,471
Medicare patients
144
Services billed
489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →